Trials / Completed
CompletedNCT03222817
HPV Self-Sampling for Cervical Cancer Screening Among Transgender Men and Transmasculine Individuals
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- University of Miami · Academic / Other
- Sex
- Female
- Age
- 25 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The proposed study will examine the implementation of a Human Papillomavirus (HPV) self-sampling intervention for unscreened and under-screened transgender men and transmasculine individuals living in South Florida. The study will enroll participants to receive this cervical cancer screening intervention in community venues. The purpose of this study is to pilot the self-sampler for feasibility and acceptability within this underserved population.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | HPV self-sampling | Participants will be provided with education regarding cervical cancer screening, as well as instructions regarding how to use the HPV self-sampler. Participants will also receive referrals to trans-competent healthcare providers for follow-up screening and care. |
Timeline
- Start date
- 2018-05-12
- Primary completion
- 2018-10-17
- Completion
- 2018-10-17
- First posted
- 2017-07-19
- Last updated
- 2019-05-03
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03222817. Inclusion in this directory is not an endorsement.